Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2026-01-02 @ 2:12 PM
Study NCT ID:
NCT04241068
Status:
TERMINATED
Last Update Posted:
2025-02-21
First Post:
2020-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-22
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-22
First Submit QC Date:
None
Study First Post Date:
2020-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-31
Results First Submit QC Date:
None
Results First Post Date:
2025-02-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-31
Last Update Post Date:
2025-02-21
Last Update Post Date Type:
ACTUAL